Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment
By Ok-hee Jeon, Chaekyun Kim, Rémi-Martin Laberge, M. Demaria, Sona Rathod, A. Vasserot, Jae Wook Chung, Do Hun Kim, Yan Poon, Nathaniel E. David and 4 more. Nature Medicine, 2017
1,334 citations recorded by the source corpus.
Subfields: Cancer Research, Microbiology, Rheumatology
View Paper: https://www.semanticscholar.org/paper/53c54ba96c49cd92f21d4da0aa26a80dd0322f36
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Jun Guo
- Xiuqing Huang
- A. Alimonti
- Linli Zheng
- A. Calcinotto
- L. Dou
- Mingjing Yan
- Ziji Zhang
Citations in the corpus
- Aging and aging-related diseases: from molecular mechanisms to interventions and treatments (2022, background): “In one mouse model, injection of UBX0101 selectively eliminated senescent cells and reduced proteoglycan loss, which alleviated the cartilage degradation and pain caused by OA.339 Fenofibrate, a PPARα agonist, clears SAβ-gal-positive chondrocytes by promoting apoptosis.595 Fisetin, a flavonoid drug,”
- Cellular Senescence: Aging, Cancer, and Injury. (2019, background): “Therefore, therapies which selectively eliminate senescent cells may be effective to both prevent and treat osteoarthritis (167).”
- The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritis. (2020, background): “metabolic alterations, and senescence, and all of these factors are also known as stressors (Bierma-Zeinstra and van Middelkoop, 2017; Courties et al., 2017; Jeon et al., 2017; Scanzello, 2017).”